Stock Events

Medpace 

€306.1
115
-€0.9-0.29% Today

Statistics

Day High
306.1
Day Low
306.1
52W High
-
52W Low
-
Volume
0
Avg. Volume
-
Mkt Cap
9.38B
P/E Ratio
31.54
Dividend Yield
-
Dividend
-

Upcoming

Earnings

21OctExpected
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Next
2.31
2.54
2.77
3
Expected EPS
2.5254798961800002
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 01P.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Show more...
CEO
Dr. August James Troendle M.D.
Employees
5800
Country
US
ISIN
US58506Q1094
WKN
000A2APTV

Listings